Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-25 4:10 pm Sale | 13D | ADC THERAPEUTICS SA SHS ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 2,255,719 2.7% | -4,074,829 (-64.37%) | View |
| 2024-02-14 4:26 pm Purchase | 13G | ADC THERAPEUTICS SA SHS ADCT | Redmile Group LLC | 15,328,317 18.8% | 1,763,068 (+13.00%) | View |
| 2024-02-13 09:47 am Purchase | 13G | ADC THERAPEUTICS SA SHS ADCT | Prosight Management LP | 6,471,800 8% | 2,167,282 (+50.35%) | View |
| 2024-02-12 10:13 am Unchanged | 13G | ADC THERAPEUTICS SA SHS ADCT | ASTRAZENECA PLC AZN | 4,011,215 4.88% | 0 (Unchanged) | View |
| 2023-04-28 4:08 pm Unchanged | 13D | ADC THERAPEUTICS SA SHS ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 6,330,548 7.9% | 0 (Unchanged) | View |
| 2023-04-14 5:45 pm Purchase | 13G | ADC THERAPEUTICS SA SHS ADCT | Prosight Management LP | 4,304,518 5.3% | 4,304,518 (New Position) | View |
| 2023-04-10 09:37 am Sale | 13G | ADC THERAPEUTICS SA SHS ADCT | FMR LLC | 40,444 0.05% | -4,613,009 (-99.13%) | View |
| 2023-02-10 5:18 pm Purchase | 13G | ADC THERAPEUTICS SA SHS ADCT | Redmile Group LLC | 13,565,249 16.8% | 6,114,220 (+82.06%) | View |
| 2023-02-09 08:23 am Sale | 13G | ADC THERAPEUTICS SA SHS ADCT | FMR LLC | 4,653,453 6.05% | -3,019,220 (-39.35%) | View |
| 2023-02-06 2:56 pm Sale | 13D | ADC THERAPEUTICS SA SHS ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 6,330,548 7.9% | -12,000,000 (-65.46%) | View |
| 2022-12-22 7:30 pm Unchanged | 13D | ADC THERAPEUTICS SA SHS ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 18,330,548 23.8% | 0 (Unchanged) | View |
| 2022-12-09 4:06 pm Sale | 13D | ADC THERAPEUTICS SA SHS ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 18,330,548 23.8% | -3,088,182 (-14.42%) | View |
| 2022-12-08 09:07 am Sale | 13D | ADC THERAPEUTICS SA SHS ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 21,418,730 27.8% | -775,000 (-3.49%) | View |
| 2022-02-14 5:07 pm Purchase | 13G | ADC THERAPEUTICS SA SHS ADCT | Redmile Group LLC | 7,451,029 9.7% | 692,235 (+10.24%) | View |
| 2022-02-09 09:09 am Sale | 13G | ADC THERAPEUTICS SA SHS ADCT | FMR LLC | 7,672,673 9.999% | -88,912 (-1.15%) | View |
| 2021-04-12 1:05 pm Unchanged | 13G | ADC THERAPEUTICS SA SHS ADCT | FMR LLC | 7,761,585 10.116% | 0 (Unchanged) | View |
| 2021-02-16 4:05 pm Purchase | 13G | ADC THERAPEUTICS SA SHS ADCT | Redmile Group LLC | 6,758,794 8.81% | 6,758,794 (New Position) | View |
| 2021-02-10 4:01 pm Purchase | 13G | ADC THERAPEUTICS SA SHS ADCT | ASTRAZENECA PLC AZN | 4,011,215 5.23% | 4,011,215 (New Position) | View |
| 2021-02-08 10:15 am Sale | 13G | ADC THERAPEUTICS SA SHS ADCT | FMR LLC | 7,761,585 9.999% | -148 (-0.00%) | View |
| 2020-12-10 09:15 am Purchase | 13G | ADC THERAPEUTICS SA SHS ADCT | FMR LLC | 7,761,733 10% | 7,761,733 (New Position) | View |